Episode 261: 260. SGLT2 Summary Recap

Episode 261: 260. SGLT2 Summary Recap


Diabetic patient- Empagliflozin prevents death from cardiovascular causes: NNT 46 per 3.1 yrs ($600 a month, 1 million dollars per life saved)



-HFpEF- SGLT2 inhibitors do not prevent death and cost roughly $364,000 to prevent one hospitalization



-HFrEF -Using Cox models, only Dapagliflozin has mortality benefit (NNT 53) and comes at a cost of $229,914 prevent one cardiovascular death. (117,126$$$ dap for hospitalization)


Avsnitt(387)

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
rss-jossan-nina
inga-beiga-morsor
alska-oss
rss-vuxna-pa-latsas
not-fanny-anymore
johannes-hansen-podcast
angestpodden
sexnoveller-deluxe
rss-viktmedicinpodden
sa-in-i-sjalen
brottarbroder
sova-med-dan-horning
rss-psykoterapipodden
rss-the-house-podcast-3
rss-sjalsligt-avkladd
rss-basta-livet
sex-pa-riktigt-med-marika-smith
tyngre-traningssnack